At Issue: Should Medicare Be Allowed to Negotiate Drug Prices?

Bending the health care cost curve in the right direction will require new mechanisms to control drug prices. Drug spending in the United States increased 12 percent in 2014, faster than nearly every other health care spending component and the highest rate in more than a decade. Overall, Medicare spending grew 5.5 percent, but drug spending grew 16.9 percent, hardly a sustainable rate.

Download “Should Medicare Be All0wed to Negotiate Drug Prices?